Derek Archilla

Synergy Pharmaceuticals Inc (NASDAQ: SGYP) announced an offering of 21 million shares of its common stock at $2.58 per share in November, and at least one Wall Street analyst said another dilutive offering is imminent. The Analyst Oppenheimer's Derek Archila downgraded Synergy...